Edoxaban 15 MG Oral Tablet [Savaysa] — RxCUI 1599549
RxNorm drug concept · Semantic branded drug
RxCUI 1599549
Semantic branded drug · SBD
● Current RxNorm concept 3 FDA products
20 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1599549
Official nameEdoxaban 15 MG Oral Tablet [Savaysa]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSavaysa 15 MG Oral Tablet; Savaysa 15 MG (as edoxaban tosylate 20.2 MG) Oral Tablet
FDA products mapped3
Package NDCs mapped20
Reported Medicaid activity (SDUD)210 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Edoxaban: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's a blood thinner. It lowers the risk of stroke and clots traveling through the body in people with nonvalvular atrial fibrillation. It also treats clots in the legs (deep vein...
- Take one tablet by mouth once a day, with or without food. If you forget, take it as soon as you remember the same day, then go back to normal the next day. Never double up. If swa...
- How do I take it, and what if I miss a dose?
- Bleeding is the most common one, and you may also see anemia, rash, or abnormal liver tests. Call your doctor right away for bleeding that won't stop, black or bloody stools, or vo...
🕸️ Concept Web — How Edoxaban 15 MG Oral Tablet [Savaysa] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Edoxaban 15 MG Oral Tablet [Savaysa]
RxCUI 1599549 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Edoxaban
1599538IN
-
Edoxaban
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Savaysa
1599544BN
-
Savaysa
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Edoxaban Oral Tablet
1599542SCDF -
Edoxaban Oral Product
1599540SCDG -
Edoxaban Pill
1599541SCDG -
Edoxaban Oral Tablet [Savaysa]
1599546SBDF -
Savaysa Oral Product
1599547SBDG -
Savaysa Pill
1599548SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Edoxaban Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Edoxaban 15 MG Oral Tablet
1599543SCD -
Edoxaban 15 MG
1599539SCDC -
Edoxaban 15 MG [Savaysa]
1599545SBDC
-
Edoxaban 15 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Edoxaban 15 MG Oral Tablet
SCD · 1599543 -
Edoxaban 15 MG
SCDC · 1599539 -
Edoxaban Oral Tablet
SCDF · 1599542 -
Edoxaban Oral Product
SCDG · 1599540 -
Edoxaban Pill
SCDG · 1599541
Brand-Name Concepts
-
Edoxaban 15 MG [Savaysa]
SBDC · 1599545 -
Edoxaban Oral Tablet [Savaysa]
SBDF · 1599546 -
Savaysa Oral Product
SBDG · 1599547 -
Savaysa Pill
SBDG · 1599548 -
Savaysa
BN · 1599544
📦 FDA Products & Package NDCs
3 products · 20 package NDCs
20 package NDCs map to RxCUI 1599549 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65597-0201-07 | 7 TABLET, FILM COATED in 1 BOTTLE (65597-201-07) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0201-10 | 10 TABLET, FILM COATED in 1 BLISTER PACK (65597-201-10) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0201-30 | 30 TABLET, FILM COATED in 1 BOTTLE (65597-201-30) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0201-50 | 500 TABLET, FILM COATED in 1 BOTTLE (65597-201-50) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0201-70 | 7 TABLET, FILM COATED in 1 BLISTER PACK (65597-201-70) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0201-90 | 90 TABLET, FILM COATED in 1 BOTTLE (65597-201-90) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0202-05 | 50 BLISTER PACK in 1 CARTON (65597-202-05) / 1 TABLET, FILM... | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0202-07 | 7 TABLET, FILM COATED in 1 BOTTLE (65597-202-07) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0202-10 | 100 BLISTER PACK in 1 CARTON (65597-202-10) / 1 TABLET, FIL... | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0202-30 | 30 TABLET, FILM COATED in 1 BOTTLE (65597-202-30) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0202-50 | 500 TABLET, FILM COATED in 1 BOTTLE (65597-202-50) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0202-70 | 7 TABLET, FILM COATED in 1 BLISTER PACK (65597-202-70) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0202-90 | 90 TABLET, FILM COATED in 1 BOTTLE (65597-202-90) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0203-05 | 50 BLISTER PACK in 1 CARTON (65597-203-05) / 1 TABLET, FILM... | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0203-07 | 7 TABLET, FILM COATED in 1 BOTTLE (65597-203-07) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0203-10 | 100 BLISTER PACK in 1 CARTON (65597-203-10) / 1 TABLET, FIL... | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0203-30 | 30 TABLET, FILM COATED in 1 BOTTLE (65597-203-30) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0203-50 | 500 TABLET, FILM COATED in 1 BOTTLE (65597-203-50) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0203-70 | 7 TABLET, FILM COATED in 1 BLISTER PACK (65597-203-70) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
| 65597-0203-90 | 90 TABLET, FILM COATED in 1 BOTTLE (65597-203-90) | SAVAYSA | Daiichi Sankyo Inc. | 2015-01-31 |
Observed labelers:
Daiichi Sankyo Inc. (20)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.